Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
8,534 total articles
Jensen Huang's recent push against bespoke ASICs has exposed Nvidia to renewed competitive, pricing and regulatory risk. We are downgrading the stock and proposing a mid-term short: entry at $680.00, target $520.00, stop loss $760.00. The trade targets a re-rating driven by demand shifts, ASP pressure and coalition-driven customer negotiation.
Allegro is a niche leader in sensor and high-voltage power ICs that stands to benefit from a shift to 800-VDC architectures across EVs, robotics and industrial systems. Strong top-line execution, healthy free cash flow and improving leadership bench make a buyable setup after recent consolidation. The trade below balances upside toward the 52-week …
Palantir has the revenue growth, margins and cash-flow profile that can support a dramatically higher equity value if AIP achieves commercial scale. At $132.62 today we lay out a concrete trade: entry $132.62, target $602.00 (ambitious multi-year target consistent with ~40% annualized returns through 12/31/2030), stop $102.00. The trade is high-ris…
Avio is a leveraged, high-beta play on Europe’s sovereign space agenda. With Vega family upgrades, a growing pipeline of European institutional demand, and near-term contract catalysts, this is a speculative buy for risk-tolerant investors looking for asymmetric upside. Use tight sizing and a well-defined stop - this is a high-risk, event-driven tr…
EOS is a closed-end equity income fund trading near the low end of its 52-week range with an 8.29% yield, a sub-1.0 PB and a single-digit P/E. For yield seekers comfortable with CEF dynamics, a mid-term long (45 trading days) offers upside to the 52-week high while collecting monthly distributions. Manage position size around the stop and keep an e…
Tenax Therapeutics (TENX) has run up into a near-term data event for TNX-103. The balance sheet looks clean, market cap is light-moderate for a Phase 3 biotech, and technical momentum is strong. That combination argues for a Hold for existing holders and a cautious, size-limited long only on a defined pullback or with tight stops ahead of the Augus…
Meta's plan to sell excess AI compute as 'Meta Compute' reframes expensive data-center capex from a pure cost sink into a revenue generator. Combined with a still-robust Family of Apps business (33% y/y revenue growth cited in recent coverage) and attractive cash flow ($48.25B FCF), the stock looks primed for a re-rating. This is a swing trade idea…
Energy Transfer (ET) is a classic dip-and-buy candidate right now. The units trade near $19.34, yield roughly 7% with a $1.35 annual distribution, and sit below the 50-day moving average but above short-term EMAs as momentum quietly turns constructive. Fundamentals - free cash flow of $3.615B, EV/EBITDA ~8.6 and a market cap near $66.6B - give a re…
Nvidia has the balance sheet, cash flow and market position to monetize a newly accessible $200 billion opportunity in AI infrastructure. The stock is trading below key moving averages after a recent pullback; this trade targets a retest of the prior highs while keeping downside contained with a disciplined stop. Valuation is rich, so sizing and an…
Meta is down from its 52-week highs but fundamentals remain intact: double-digit revenue growth, healthy free cash flow, a clean balance sheet and a plausible new cloud revenue stream. This trade idea lays out an entry at current levels, a protective stop and a realistic upside target over a 180-trading-day horizon while flagging key risks that cou…
enCore Energy is a small-cap uranium developer with in-situ recovery projects in the U.S. A successful project license renewal would materially de-risk the path to production and could trigger a rapid re-rating. This trade outlines an actionable entry, stop and targets around that event with clear time horizons and risk controls.
DXC is trading cheaply on traditional multiples despite positive free cash flow, improving technicals, and growing partnerships around AI and sovereign cloud. At current levels the risk-reward favors a long position to $16.45 over the next 180 trading days, with a protective stop below $8.50.
OR Royalties is shifting from scale-up to harvest mode: rising gold equivalent production guidance, a recent $115M portfolio buy that adds near-term ounces, and an 18% dividend bump point to accelerating cash returns. At a $5.77B market cap and a sub-$31 share price entry, the risk/reward looks attractive for a long-term trade with a tight stop.
AutoNation (AN) trades at roughly 10x earnings, 0.23x sales and a sub-3x price-to-book while producing high returns on equity. With a market cap near $6.3B and a capital-allocation story centered on returning cash to shareholders, the risk/reward favors a long-term (180 trading days) long. This trade lays out an entry at $187.00, a stop at $170.00 …
CoreWeave's unit economics are starting to inflect as capacity scales. The stock trades at $87.26 with a market cap near $47.6B while the business still posts negative free cash flow and high leverage. This trade idea backs a long position into signs of margin recovery, balanced by clear stops for competition and capital risks.
Boston Scientific (BSX) has plunged from last year's highs and now sits near multi-month support with attractive cash generation and a manageable balance sheet. This is a tactical long trade: enter near $44.20, limit risk with a $39.50 stop, and target $60 — a mid-term trade that leans on clinical wins, TAVR exposure and improving technical momentu…
Palantir is converting AI hype into recurring, enterprise-grade infrastructure. Strong topline growth, expanding margins, and healthy cash flow justify a tactical long. This trade idea lays out an entry at $133.41, a stop at $116.00 and a primary target at $170.00 over a mid-term 45 trading-day horizon, with clear catalysts and risks to watch.
Meta's stock has been punished on concerns about AI infrastructure spending and a broad rotation out of the Magnificent Seven. The selloff ignores two critical facts: FoA ad acceleration driven by AI is delivering 33% revenue growth, and Meta can monetize excess data-center capacity via a cloud offering—turning a perceived expense into a new revenu…
Centene (CNC) has taken its lumps from membership declines and margin pressure, but the market has likely over-discounted a company that still generates strong free cash flow, trades at a deep multiple to sales, and sits near short-term technical support. This trade idea lays out a clear entry at the current price, a stop to limit downside, and tar…
Enlight Renewable Energy (ENLT) is a diversified renewables platform with growing project scale in the U.S., Europe and MENA. The stock is best accumulated on pullbacks; our tactical entry at $84 with a $110 target and $72 stop fits a long-term 180 trading day view that captures project IV and operational ramp from large financed assets.
Palantir's business metrics are still impressive — double-digit to triple-digit growth in key lines and healthy margins — yet the stock has corrected sharply from its late-2025 highs. This trade idea proposes a tactical long entry on weakness around $130 with a stop under $118 and a primary target at $170 over a mid-term horizon. The idea hinges on…
Nebius (NBIS) plunged on news that Meta plans to monetize excess AI compute. The sell-off is a sentiment shock, not a confirmed loss of customers. With contracted power capacity north of 4 GW, aggressive 2026 revenue guidance of $3.0-3.4B, and improving cash flow metrics reported in June, Nebius offers a high-risk, high-reward swing entry. Trade pl…
Apple may be preparing a new iPhone pricing tier aimed at expanding volume and services adoption. Given the company's cash generation, large buyback capacity and current technical posture, a disciplined long trade can capture upside from re-rated multiples or stronger-than-feared unit growth while controlling downside risk.
Southwest (LUV) has the operational footprint and recent capital-return actions to accelerate gains if jet fuel stabilizes under $70. The stock trades around $50.75 with a market cap near $24.8B, P/E ~32 and positive technical momentum. This trade idea lays out an entry at $51.00, a stop at $46.00 and a target of $60.00 on a long-term horizon (180 …
Summit Therapeutics (SMMT) is a clinical-stage biotech with a near-term regulatory binary and a market cap around $12.07B. The FDA accepted its BLA for ivonescimab with a PDUFA date of 11/14/2026, and the stock trades well below its 52-week high despite a meaningful short interest. This trade idea outlines a long entry at $15.55, a stop at $12.50 a…
